In addition, plasma matrix metalloproteinase-9 (MMP-9) is reported to be associated with the degradation of certain TJs in laboratory studies and has been correlated with the severity of hemorrhagic transformation after cardioembolic stroke [11,12]. Here, MMP9 is linked to cardioembolic stroke.